February 28, 2024

We are creating some awesome events for you. Kindly bear with us.

Investing in cutting edge tech to boost research in diverse fields

New Zealand’s University of Canterbury is investing NZ$ 2.6 million in cutting-edge new research equipment that will strengthen research and teaching excellence in diverse fields.

These fields include biomedicine, engineering, drug design, and nanotechnology.

As reported, the new specialist research equipment will be unique in New Zealand and signals that the University is actively rebuilding its research profile nationally and internationally.

The major investments

These are the first major investments, backing fundamental and applied research into structural biology and new drug discovery, protein science and structural biology, and nanostructure engineering.

The funding will cover the following:

  1. Two-photon polymerization nanoscale 3D printer

The Photonic Professional GT2 two-photon polymerization-based nanoscale 3D printer will be the first in New Zealand, and only one of a few worldwide of the newly-released second generation version.

It will further strengthen research and teaching excellence in nanotechnology and innovative additive manufacturing.

These areas constitute transformational technology for high-value domestic industries.

The UC Nanofabrication Facility, within the University’s College of Engineering, is the most technically complete Micro- and Nanofabrication facility in New Zealand.

Nanoscale 3D printing based on two-photon polymerization is one of the key new nanofabrication technologies established in recent years.

This is the first and only technology to bridge the gap between 2D high-resolution patterning techniques and conventional large-scale, large-feature size 3D printing available through the Additive Manufacturing.

It will allow researchers and external users to build complex, arbitrarily shaped structures with minimum feature sizes in the nanometre range.

  1. Native mass spectrometer

The acquisition of a native mass spectrometer will be a New Zealand-first, providing exciting new capability and enhancing the University’s reputation for research excellence in the area of protein science and structural biology.

A native mass spectrometer is specifically designed to analyse very large molecules, like proteins in their natural state.

The study and manipulation of native proteins and their interactions is of great importance in drug design, medical research, biotechnology development and bioengineering.

  1. Biomolecular NMR facility

The biomolecular NMR (BioNMR) probe will help develop new capability in structural biology and drug discovery at the University.

As a fundamental and versatile biomolecular method, investment in this device will boost biological and biomedical research and attract new research funding.

Nuclear magnetic resonance spectroscopy (NMR) is a powerful technique that has found many applications in medical and industry research.

Developments in technology and methodology in the past decades have allowed NMR to become one of the most important techniques for studying large biological molecules, including proteins, DNA and carbohydrates.

It can be used to investigate diverse biological problems including in drug screening and drug design.

NMR is the only structural method to study intrinsically-disordered proteins, as well as for following protein folding and misfolding, which is highly relevant to disease research including dementia and cancer.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend